Back to catalog
Reference informationOr call 907-252-1640
Retatrutide 15mg
Triple-agonist research peptide
$150reference price
Retatrutide is a novel triple-agonist peptide targeting GLP-1, GIP and glucagon receptors. Currently in clinical research for metabolic studies. 15mg lyophilized powder per vial. Reconstitute with bacteriostatic water and store refrigerated at 2–8°C after reconstitution. For research use only — not for human consumption.
For research use only. Not for human consumption.
HPLC verified
Cold chain
Lyophilized
Third-party lab verification
Every batch is tested by an independent laboratory using RP-HPLC to confirm identity, purity, and endotoxin levels. Sample results for Retatrutide 15mg shown below — lot-specific COAs available on request.
Lot-specific COA available on request — call 907-252-1640 with your order number.
Illustrative sample — request your lot's COA via 907-252-1640